Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
599 participants
OBSERVATIONAL
2007-09-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
By obtaining baseline BMD and monitoring for Skeletal Related Events (SREs), we hope to identify that specific sub-set of patients who would most benefit from the treatment. Using a prospective, observational study design, we propose monitoring how physicians manage CTIBL in their patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Normal - BMD with T-score at or above -1.0
No interventions assigned to this group
2
Osteopenic - BMD with T-score between -1.1 and -2.4
No interventions assigned to this group
3
Osteoporotic - BMD with T-score at or below -2.5
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients for whom Androgen Deprivation Therapy (ADT) with Zoladex® is indicated for at least 1 year.
* Patients started on Zoladex® within the last 4 months.
Exclusion Criteria
* Known hypersensitivity to Goserelin Acetate or any of the components found in Zoladex®.
* Any concurrent condition that would make it undesirable, in the physician's opinion, for the subject to participate in the study or would jeopardize compliance with the protocol.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
CMX Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard W Casey, M.D.
Role: PRINCIPAL_INVESTIGATOR
CMX Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Male Health Centre
Toronto, Ontario, Canada
Dr. Roger Buckley
Willowdale, Ontario, Canada
ABHM Associates
Windsor, Ontario, Canada
Dr. Louis-Rene Barrette
Chicoutimi, Quebec, Canada
Recherches Cliniques Theradev
Granby, Quebec, Canada
Polyclinique Med Concorde
Laval, Quebec, Canada
Ultra-Med Inc.
Point Claire, Quebec, Canada
Clinique d'Urologie du Saguenay
Saguenay, Quebec, Canada
Dr. John A. Warner
Burnaby, British Columbia, Canada
Southern Interior Medical Research Corporation
Kelowna, British Columbia, Canada
Nanaimo Urology Associates
Nanaimo, British Columbia, Canada
Central Island Research Centre
Port Alberni, British Columbia, Canada
Andreou Research
Surrey, British Columbia, Canada
Bruce W. Palmer Urology Inc.
Kentville, Nova Scotia, Canada
Dr. Jonathan L. Giddens
Brampton, Ontario, Canada
Brantford Urology Research Medical Arts Bldg.
Brantford, Ontario, Canada
G. Kenneth Jansz Medicine Professional Corporation
Burlington, Ontario, Canada
Dr. Richard Sowery
Burlington, Ontario, Canada
Northern Urology Centre
Greater Sudbury, Ontario, Canada
Guelph Urology Associates
Guelph, Ontario, Canada
Dr. Alvaro Morales
Kingston, Ontario, Canada
GU Trials Markham
Markham, Ontario, Canada
Mor Urology Inc
Newmarket, Ontario, Canada
Medical & Dental Bldg
North Bay, Ontario, Canada
Stanley Flax Medicine Professional Corporation
North York, Ontario, Canada
York-Finch Med Centre
North York, Ontario, Canada
The Fe/Male Health Centres
Oakville, Ontario, Canada
Orillia Urology Associates
Orillia, Ontario, Canada
Urotec
Oshawa, Ontario, Canada
Mahoney Medicine Professional Corporation
Ottawa, Ontario, Canada
2150935 Ontario Inc
Owen Sound, Ontario, Canada
Kawartha Urology Associates
Peterborough, Ontario, Canada
The Medical Centre
Peterborough, Ontario, Canada
Dr. Allan Abramovitch
Scarborough Village, Ontario, Canada
Dr. Peter Roney
Smiths Falls, Ontario, Canada
West Arthur Place
Thunder Bay, Ontario, Canada
Dr. Edward Woods
Toronto, Ontario, Canada
Centre de Récherche en Urologie de Lanaudiére
Saint Charles-Baromee, Quebec, Canada
Westmount Med Bldg
Westmount, Quebec, Canada
Medical Arts Bldg
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AZ-CMX-03
Identifier Type: -
Identifier Source: org_study_id